ArticleFrontiers in dental medicine2025
Oral tolerance, a potential driver of systemic disease risk in periodontal patients.
Article in Frontiers in dental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Oral-Gut-Immune-Nutrition Axis in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic Implications.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontal disease is a recognized risk factor for sepsis, infective endocarditis, and cardiovascular disease. Oral bacteria, including viridans group of Streptococci, abundant in healthy oral microbiota, are frequently implicated in bacteremia and chronic inflammation, both contributing factors to systemic diseases. Yet the immunological mechanisms linking oral and systemic disease remain incompletely defined. This article proposes that "oral tolerance"-the immune system's suppression of responses to antigens repeatedly encountered via the oral route-may heighten susceptibility to systemic diseases, by impairing early systemic innate immune engagement with oral bacteria entering the bloodstream. Specifically, tolerogenic-signaling by gut-associated lymphoid tissue may condition circulating innate immune cells toward a regulatory phenotype, delaying effective pathogen clearance and promoting cytokine disorientation. This brief review outlines mechanistic insights, explores microbial influences, and suggests experimental approaches, aiming to advance research in oral-systemic health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.